Drugs : Dr Reddy
Drugs Dr Reddy’s announces the launch of Pantoprazole Sodium delayed-released tablets Dr Reddy’s Laboratories has launched Pantoprazole Sodium Delayed-Released tablets(20mg […]
Drugs Dr Reddy’s announces the launch of Pantoprazole Sodium delayed-released tablets Dr Reddy’s Laboratories has launched Pantoprazole Sodium Delayed-Released tablets(20mg […]
A recent study shows that a new vaccine can prevent tuberculosis in people with HIV.
Biodesign programme to be launched in SingaporeStanford University Biodesign Program and Singapore’s Agency for Science, Technology & Research, and the […]
Greek scientists develop heart attack calculator Researchers have developed a quick and easy artificial intelligence approach to successfully calculate a […]
TCG Lifesciences conferred excellence award by Inst of Economic Studies TCG Lifesciences Limited has been conferred with 'Excellence Award' and […]
Idhasoft to improve University of Pennsylvania’s tracking software University of Pennsylvania Health System Department of pharmacy selected Idhasoft mobility division […]
The US Food and Drug Administration (FDA) have approved a mobile radiology application. This application allows physicians to view medical images on Apple’s iPhone and iPad devices.
The University of Pittsburgh scientists have developed a device which sprays stem cells on to burned skin, allowing the healthy skin to grow again.
Scientists at Oxford Medical Diagnostics are developing a device that allows people with diabetes to monitor their condition without finger-prick testing.
Clinical Research in India is expected to grow to a INR 10,000 crore industry by 2010 spelling an opportunity of 50,000 jobs within India.
The Indian Council of Medical Research (ICMR) will start phase I clinical trials to test a combination of two AIDS vaccine candidates.
If studies in the West talk of NeuroAIDS and how the virus can sneak into the brain to cause dementia, back home in Pune, experts at the National AIDS Research Institute (NARI) have planned an ambitious study to find the prence of neurocognitive impairment in HIV infected individuals.
An Indian scientist has discovered a molecule which he claims can be a harbinger for a single drug therapy to treat tuberculosis and replace the current costly multi-drug treatment for the killer disease.